by Vivian Frankel | Nov 8, 2022 | Compounding Pharmacy, Salon
January: Fireside Chat – Creating Protocols for Effective Treatment Of Disorders Effecting the Brain How this came about, Treating Vets with traumatic brain injuries and ptsd – case study Demonstrate applications that can be applied to a wide variety of issues...
by Vivian Frankel | Aug 17, 2021 | 503A, 503B, Announcements, Article, Compounding Pharmacy, Regulatory, Speaker Announcement
FDA added to Compounding Pharmacies Grand Salon Agenda MEET TOP FDA POLICY MAKER AT PHARMASALON’S COMPOUNDING PHARMACIES GRAND SALON IN OCTOBER Tracy Rupp, PharmD, MPH, RD Consumer Safety Officer Office of Compounding Quality and Compliance Office of Compliance,...
by Vivian Frankel | Jun 22, 2021 | Article, Compounding Pharmacy, Headline
Meeting Tougher PPE Standards a Manageable Task By Gina Shaw – Pharmacy Practice News Matt Kelm, PharmD, MHA Complying with new, more stringent requirements for personal protective equipment (PPE) under USP Chapter <800> can be done without unduly...
by Vivian Frankel | Jun 18, 2021 | 503A, 503B, Business, Compounding Pharmacy, Podcast Episodes, Quality, Regulatory
click here to listen to the podcast My name is Karla Palmer and with me are two industry experts, Travis, Leeah at QuVa, pharma and Kimberly Kiefer, who is at Empower, and both of them can give you a little bit of introduction of what their background is with respect...
by Vivian Frankel | Feb 5, 2021 | Compounding Pharmacy, Headline
FDA approved a new drug application (NDA) for Veklury (remdesivir), a drug indicated for adults and pediatric patients (12 years of age and older and weighing at least 40 kg) for the treatment of COVID-19 requiring hospitalization on October 22, 2020. The Veklury...